Understanding Engagement Trends in Chondrosarcoma Clinical Trials

NCT06029478 · tracked via the Priya Life Science USA tracker

Sponsor

Power Life Sciences Inc.

Phase

Observational

Started

2024-10

Last updated

2023-09-08

Condition(s) studied

Chondrosarcoma

Study summary

Taking part in medical research usually favors a particular demographic group. But there is limited research available to explain what trial attributes affect the completion of these specific demographic groups.

This study will admit a wide range of data on the clinical trial experience of chondrosarcoma patients to determine which factors prevail in limiting a patient's ability to join or finish a trial.

It will also try to analyze data from the perspective of different demographic groups to check for recurring trends which might yield insights for the sake of future chondrosarcoma patients.

Eligibility

Sex

ALL

Min age

18 Years

Max age

—

Healthy volunteers

Inclusion Criteria: * Aged ≥ 18 years old * Able to comprehend the investigational nature of the protocol and provide informed consent * Diagnosis of chondrosarcoma Exclusion Criteria: * No diagnosis of chondrosarcoma confirmed * Inability to perform regular electronic reporting * Patient does not understand, sign, and return consent form

Primary outcome measure(s)

Number of chondrosarcoma patients who decide to enroll in a clinical trial — 3 months
Rate of chondrosarcoma patients who remain in clinical trial to trial completion — 12 months

Trial sites (1)

Facility	City	Region	Status
Power Life Sciences	San Francisco	California

More Power Life Sciences Inc. trials in the USA

Assessing the Experience of Patients Undergoing Follicular Lymphoma Clinical Research Starting soon

Navigating the Clinical Research Process for Lymphoma Starting soon

Investigating Participation Patterns of Patients in Atopic Dermatitis Clinical Trials Starting soon

Evaluating the Occurrence of Participation Trends Among Weight Loss Clinical Trials Patients Starting soon

Determining Patterns In Trial Experiences of Recurrent Prostate Cancer Patients Starting soon

Other trials for the same condition

Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 Mutations Active, not recruiting

A Study to Evaluate the Utilization of 3D Printed Models in Pre-Operative Planning Recruiting

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06029478 on ClinicalTrials.gov ↗ ← All trials in the USA